Congenital myopathy
Gene: CASQ1EnsemblGeneIds (GRCh38): ENSG00000143318
EnsemblGeneIds (GRCh37): ENSG00000143318
OMIM: 114250, Gene2Phenotype
CASQ1 is in 4 panels
7 reviews
Ida Ertmanska (Genomics England Curator)
Comment on phenotypes: OMIM phenotype accessed 12th Nov 2025.Created: 12 Nov 2025, 12:26 p.m. | Last Modified: 12 Nov 2025, 12:26 p.m.
Panel Version: 6.39
As reviewed previously, individuals affected by CASQ-1 related myopathy experience adult-onset symptoms. Therefore, this gene is not in scope for the Congenital myopathy panel.Created: 12 Nov 2025, 12:25 p.m. | Last Modified: 12 Nov 2025, 12:25 p.m.
Panel Version: 6.38
Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
Phenotypes
Myopathy, vacuolar, with CASQ1 aggregates, OMIM:616231
Publications
Arina Puzriakova (Genomics England Curator)
The rating of this gene has been updated from Amber to Red following NHS Genomic Medicine Service approval.Created: 29 Jul 2022, 1:47 p.m. | Last Modified: 29 Jul 2022, 1:47 p.m.
Panel Version: 2.88
Zornitza Stark (Australian Genomics)
OMIM notes adult onset
PMID: 30258016 - 22 patients (12 families) where 21/22 carried a founder mutation p.Asp244Gly.
- Patients presented with adult onset proximal weakness, quadricep atrophy and 3/22 with cardiac involvement.
- Some patients were asymptomatic and diagnosed by elevated creatine kinase.
- Youngest age at onset was 12 years old, but only 2/22 were symptomatic <30 years of age.
PMID: 25116801 - 8 patients (4 families) with mild myopathy. All patients were heterozygous for the founder mutation p.Asp244Gly. Patients were aged 23-58 years old at the time of analysis, none mentioned to have childhood onset.
PMID: 26136523 - functionally shows that missense cause both wildtype and mutation protein to aggregate and mislocalise -> evidence of dominant negative mechanism. Lack of NMD predicted variants supports this finding.
Summary: Rare reports of childhood onset, none congenitalCreated: 15 Jun 2020, 8:40 a.m. | Last Modified: 15 Jun 2020, 8:40 a.m.
Panel Version: 2.5
Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Phenotypes
Myopathy, vacuolar, with CASQ1 aggregates 616231
Publications
Louise Daugherty (Genomics England Curator)
Gene rating and review submitted by Rachael Mein, Viapath Guy's Hospital February 2019 on on behalf of London South GLH for the GMS Neurology specialist test group.Created: 30 Apr 2019, 10:09 a.m.
Rachael Mein (Viapath at Guy's Hospital)
Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
Phenotypes
Myopathy, vacuolar, with CASQ1 aggregates 616231
Publications
Variants in this GENE are reported as part of current diagnostic practice
Helen Brittain (Genomics England Curator)
Comment when marking as ready: Adult affected with mild myopathy and therefore phenotype not appropriate for inclusion on this panel based upon the current evidence.Created: 7 Mar 2017, 4:27 p.m.
Comment on list classification: Associated with the phenotype but age of onset well into adulthood in most cases found. Therefore not considered appropriate.Created: 7 Mar 2017, 4:26 p.m.
Anna Sarkozy (Great Ormond Street Hospital)
Calsequestrin (CASQ) is the main Ca2+ buffer in the terminal cisternae, part of the so called Triad. Other forms of congenital myopathies are caused by genetic defects in components of the triad such as RYR1, ORAI1, STIM1 and now also CASQ1. patients with CASQ1 pathogenic variants usually present with high CK levels, mild proximal weakness, and myalgia. variable age at onset, mostly in adult life. muscle biopsy findings were typically myopathic with vacuolar inclusions strongly react with antibodies against SR calcium–machinery proteins and also tubular aggregates. These features are in part similar and overlapping what seen in association with other diseases associated with the triad.Created: 19 Sep 2025, 10:40 a.m. | Last Modified: 19 Sep 2025, 10:40 a.m.
Panel Version: 6.35
Calsequestrin (CASQ) is the main Ca2+ buffer in the terminal cisternae, part of the so called Triad. Other forms of congenital myopathies are caused by genetic defects in components of the triad such as RYR1, ORAI1, STIM1 and now also CASQ1. patients with CASQ1 pathogenic variants usually present with high CK levels, mild proximal weakness, and myalgia. variable age at onset, mostly in adult life. muscle biopsy findings were typically myopathic with vacuolar inclusions strongly react with antibodies against SR calcium–machinery proteins and also tubular aggregates. These features are in part similar and overlapping what seen in association with other diseases associated with the triad.Created: 19 Sep 2025, 10:40 a.m. | Last Modified: 19 Sep 2025, 10:40 a.m.
Panel Version: 6.35
Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Phenotypes
Vacuolar myopathy with CASQ1 aggregates (VMCQA)
Publications
- PMID: 30258016
Details
- Mode of Inheritance
- MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
- Sources
-
- Expert Review Red
- NHS GMS
- London South GLH
- Phenotypes
-
- Myopathy, vacuolar, with CASQ1 aggregates, OMIM:616231
- myopathy due to calsequestrin and SERCA1 protein overload, MONDO:0014546
- OMIM
- 114250
- Clinvar variants
- Variants in CASQ1
- Penetrance
- Complete
- Publications
- Panels with this gene
History Filter Activity
Set Phenotypes
Ida Ertmanska (Genomics England Curator)Phenotypes for gene: CASQ1 were changed from Myopathy, vacuolar, with CASQ1 aggregates, OMIM:616231 to Myopathy, vacuolar, with CASQ1 aggregates, OMIM:616231; myopathy due to calsequestrin and SERCA1 protein overload, MONDO:0014546
Set mode of inheritance
Arina Puzriakova (Genomics England Curator)Mode of inheritance for gene: CASQ1 was changed from MONOALLELIC, autosomal or pseudoautosomal to MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
Set publications
Arina Puzriakova (Genomics England Curator)Publications for gene: CASQ1 were set to 25116801
Set Phenotypes
Arina Puzriakova (Genomics England Curator)Phenotypes for gene: CASQ1 were changed from Vacuolar myopathy with CASQ1 aggregates (VMCQA); Myopathy, vacuolar, with CASQ1 aggregates, 616231 to Myopathy, vacuolar, with CASQ1 aggregates, OMIM:616231
Added New Source, Status Update
Arina Puzriakova (Genomics England Curator)Source Expert Review Red was added to CASQ1. Rating Changed from Amber List (moderate evidence) to Red List (low evidence)
Set Phenotypes
Louise Daugherty (Genomics England Curator)Phenotypes for gene: CASQ1 were changed from Vacuolar myopathy with CASQ1 aggregates (VMCQA) to Vacuolar myopathy with CASQ1 aggregates (VMCQA); Myopathy, vacuolar, with CASQ1 aggregates, 616231
Added New Source
Louise Daugherty (Genomics England Curator)Source NHS GMS was added to CASQ1.
Added New Source
Louise Daugherty (Genomics England Curator)Source London South GLH was added to CASQ1.
Gene classified by Genomics England curator
Helen Brittain (Genomics England Curator)This gene has been classified as Amber List (Moderate Evidence).
Gene classified by Genomics England curator
Helen Brittain (Genomics England Curator)This gene has been classified as Amber List (Moderate Evidence).
Created
Anna Sarkozy (Great Ormond Street Hospital)CASQ1 was created by anna.sarkozy
Added New Source
Anna Sarkozy (Great Ormond Street Hospital)CASQ1 was added to Congenital myopathypanel. Sources: UCL